
Varian Medical Systems, Inc. VAR
Varian Medical Systems, Inc. Book Value 2011-2026 | VAR
Book value is a financial metric that reflects the value of a company's assets minus its liabilities as of a specific date, according to accounting records. In simple terms, it is the amount that would remain for the owners of the company if all assets were sold and all debts paid off.What is included in book value
- Assets — all company resources: real estate, equipment, inventory, cash, accounts receivable, and others.
- Liabilities — all debts and financial obligations: loans, accounts payable, taxes, and other obligations.
- Assessment of the company's "real" value
Book value shows how much the company is worth according to accounting data, that is, the value of its property taking debts into account. - Comparison with market capitalization
Comparing book value and the market price of shares helps to understand whether the company is overvalued or undervalued by the market. - Indicator of financial stability
If the book value is high, it indicates the company has significant assets, which reduces risks for investors. - Key component for financial ratios
Many metrics, such as the price-to-book ratio (P/B), use book value to analyze the attractiveness of shares.
Annual Book Value Varian Medical Systems, Inc.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 66.7 M | 114 M | 53.7 M | 51.6 M | -127 M | -96.3 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 114 M | -127 M | 10.5 M |
Book Value of other stocks in the Medical instruments industry
| Issuer | Book Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
243 K | - | - | $ 810 M | ||
|
iRhythm Technologies
IRTC
|
153 M | $ 125.96 | 2.95 % | $ 4.03 B | ||
|
Repro Med Systems
KRMD
|
17 M | $ 4.06 | 2.53 % | $ 188 M | ||
|
Microbot Medical
MBOT
|
77.6 M | $ 2.17 | -1.36 % | $ 99.4 M | ||
|
Luminex Corporation
LMNX
|
199 M | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
76.5 M | - | -9.52 % | $ 20.6 M | ||
|
Alcon
ALC
|
22 B | $ 76.01 | 0.28 % | $ 40.4 B | ||
|
Ekso Bionics Holdings
EKSO
|
9.03 M | $ 11.37 | 3.46 % | $ 27.6 M | ||
|
STERIS plc
STE
|
6.62 B | $ 222.19 | 0.18 % | $ 21.9 B | ||
|
The Cooper Companies
COO
|
8.24 B | $ 64.34 | -0.12 % | $ 12.8 B | ||
|
Teleflex Incorporated
TFX
|
3.12 B | $ 135.07 | -1.09 % | $ 6.03 B | ||
|
Antares Pharma, Inc.
ATRS
|
257 M | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
411 M | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
762 M | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
388 M | - | -0.05 % | $ 10.3 B | ||
|
Milestone Scientific
MLSS
|
2.81 M | $ 0.34 | 5.75 % | $ 27.9 M | ||
|
Utah Medical Products
UTMD
|
119 M | $ 66.78 | -0.58 % | $ 216 M | ||
|
Haemonetics Corporation
HAE
|
2.45 B | $ 60.48 | 0.92 % | $ 3.04 B | ||
|
electroCore
ECOR
|
-1.71 M | $ 6.07 | -1.7 % | $ 51.5 K | ||
|
ICU Medical
ICUI
|
4.05 B | $ 122.85 | -1.58 % | $ 3.03 B | ||
|
Envista Holdings Corporation
NVST
|
5.68 B | $ 26.77 | -0.11 % | $ 4.5 B | ||
|
Isoray
ISR
|
207 M | - | 0.03 % | $ 108 M | ||
|
Intuitive Surgical
ISRG
|
17.9 B | $ 470.99 | -2.33 % | $ 168 B | ||
|
Glaukos Corporation
GKOS
|
462 M | $ 122.07 | 0.49 % | $ 5.91 B | ||
|
Masimo Corporation
MASI
|
1.05 B | $ 178.66 | 0.02 % | $ 9.52 B | ||
|
InfuSystem Holdings
INFU
|
48 M | $ 10.66 | 3.09 % | $ 220 M | ||
|
Merit Medical Systems
MMSI
|
1.58 B | $ 67.43 | -1.68 % | $ 3.99 B | ||
|
West Pharmaceutical Services
WST
|
3.18 B | $ 302.2 | -1.29 % | $ 21.8 B | ||
|
Pulse Biosciences
PLSE
|
80.7 M | $ 22.65 | -1.61 % | $ 1.53 B | ||
|
DENTSPLY SIRONA
XRAY
|
1.34 B | $ 11.96 | 0.42 % | $ 2.38 B | ||
|
Retractable Technologies
RVP
|
74.4 M | $ 0.64 | -0.92 % | $ 19.2 M | ||
|
Pro-Dex
PDEX
|
36.6 M | $ 51.96 | -0.27 % | $ 171 M | ||
|
LeMaitre Vascular
LMAT
|
394 M | $ 114.52 | 0.94 % | $ 2.59 B | ||
|
Predictive Oncology
POAI
|
47.7 M | - | - | $ 31.1 M | ||
|
STAAR Surgical Company
STAA
|
344 M | $ 26.68 | 3.93 % | $ 1.32 B | ||
|
BioLife Solutions
BLFS
|
349 M | $ 21.41 | 0.14 % | $ 986 M | ||
|
Stereotaxis
STXS
|
18.7 M | $ 1.93 | - | $ 176 M | ||
|
Baxter International
BAX
|
6.1 B | $ 18.49 | 1.85 % | $ 9.49 B | ||
|
ResMed
RMD
|
3.36 B | $ 222.02 | 0.99 % | $ 32.4 B | ||
|
AtriCure
ATRC
|
492 M | $ 29.04 | -0.82 % | $ 1.39 B | ||
|
Harvard Bioscience
HBIO
|
13.7 M | $ 6.83 | -0.44 % | $ 303 M | ||
|
NeuroMetrix
NURO
|
14.3 M | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
183 M | $ 11.09 | -0.09 % | $ 453 M | ||
|
Becton, Dickinson and Company
BDX
|
55.3 B | $ 150.22 | -1.26 % | $ 43.2 B | ||
|
Nephros
NEPH
|
8.36 M | $ 3.23 | 12.54 % | $ 33.5 M | ||
|
OraSure Technologies
OSUR
|
341 M | $ 3.01 | 0.33 % | $ 221 M | ||
|
Repligen Corporation
RGEN
|
1.96 B | $ 118.29 | 0.59 % | $ 6.59 M |